跳至主要内容
临床试验/jRCT1070230013
jRCT1070230013进行中(未招募)不适用

A clinical study of non-invasive diagnostic criteria for detrusor underactivity

TAIHO PHARMACEUTICAL CO., LTD.0 个研究点目标入组 186 人开始时间: 2023年5月11日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
186
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18age 0month 0week old over 至 No limit(—)
性别
All

入选标准

  • Written consent was given for participation in the study.
  • Age at the time of informed consent is 18 years or older.
  • Willingness to adhere to the visit schedule and procedures specified in this study, and compliance is possible
  • Of the three voiding symptoms of UAB's syndrome as defined by ICS (hypovolemia, delayed voiding, abdominal pressure voiding), having any two or more symptoms for at least 12 weeks

排除标准

  • Researchers and others judged the participation of this study to be inappropriate.

结局指标

主要结局

-

Diagnostic predictive value based on noninvasive diagnostic criteria for DU.(%)

次要结局

  • BCI (men) and PIP1 (women) tabulation
  • Urinary micro RNA analysis

研究者

相似试验